We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$26.7B
AUM Growth
+$3.85B
Cap. Flow
-$4.59B
Cap. Flow %
-17.17%
Top 10 Hldgs %
20.41%
Holding
1,231
New
232
Increased
271
Reduced
149
Closed
114
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSCI icon
851
MSCI
MSCI
$42.1B
$439K ﹤0.01%
716
NTCO
852
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$406K ﹤0.01%
+43,796
New +$534K
SANBU
853
DELISTED
Sanaby Health Acquisition Corp. I Unit
SANBU
$406K ﹤0.01%
+40,000
New +$405K
GSEVU
854
DELISTED
Gores Holdings VII, Inc. Units
GSEVU
$400K ﹤0.01%
40,000
CIVI
855
DELISTED
Civitas Resources
CIVI
$397K ﹤0.01%
8,105
-7,590
-48% -$404K
FZT.U
856
DELISTED
FAST Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
FZT.U
$394K ﹤0.01%
40,000
KAHC.U
857
DELISTED
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
$390K ﹤0.01%
38,878
-111,122
-74% -$1.12M
CMLS
858
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$377K ﹤0.01%
33,469
+3,820
+13% +$47K
SIERU
859
DELISTED
Sierra Lake Acquisition Corp. Unit
SIERU
$369K ﹤0.01%
36,903
HCIIU
860
DELISTED
Hudson Executive Investment Corp. II Unit
HCIIU
$346K ﹤0.01%
35,000
AGG icon
861
iShares Core US Aggregate Bond ETF
AGG
$138B
$345K ﹤0.01%
3,020
+1,070
+55% +$122K
DOYU
862
DouYu International Holdings
DOYU
$140M
$343K ﹤0.01%
13,000
SLAMU
863
DELISTED
Slam Corp. Unit
SLAMU
$296K ﹤0.01%
30,000
EPWR.U
864
DELISTED
Empowerment & Inclusion Capital I Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
EPWR.U
$262K ﹤0.01%
26,400
LVACU
865
DELISTED
LAVA Medtech Acquisition Corp. Unit
LVACU
$262K ﹤0.01%
+25,000
New +$253K
THACU
866
DELISTED
Thrive Acquisition Corporation Unit
THACU
$255K ﹤0.01%
+25,000
New +$253K
ANAC.U
867
DELISTED
Arctos NorthStar Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
ANAC.U
$254K ﹤0.01%
25,100
PBAXU
868
DELISTED
Phoenix Biotech Acquisition Corp. Unit
PBAXU
$252K ﹤0.01%
+25,000
New +$253K
SDACU
869
DELISTED
Sustainable Development Acquisition I Corp. Unit
SDACU
$250K ﹤0.01%
25,000
IRAAU
870
DELISTED
Iris Acquisition Corp Units
IRAAU
$249K ﹤0.01%
25,000
ACII.U
871
DELISTED
Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant
ACII.U
$248K ﹤0.01%
25,000
EXEEL
872
DELISTED
Expand Energy Corp Class C Warrants
EXEEL
$229K ﹤0.01%
7,062
-11,071
-61% -$343K
PFF icon
873
iShares Preferred and Income Securities ETF
PFF
$13.2B
$218K ﹤0.01%
5,525
IVW icon
874
iShares S&P 500 Growth ETF
IVW
$71.9B
$216K ﹤0.01%
+2,580
New +$208K
TMUS icon
875
T-Mobile US
TMUS
$196B
$207K ﹤0.01%
1,788
-151
-8% -$17.8K

Similar funds

Calamos Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Calamos Advisors held 1,231 positions worth $26.7B, up 17% from $22.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.59B in Q4 2021, closing 114 positions and reducing 149 holdings. Its most notable exit was AstraZeneca, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $169M.

  • Calamos Advisors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 81,590 shares worth $169M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $151M increase.
  • Calamos Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $29.5M.
  • Calamos Advisors fully exited AstraZeneca in Q4 2021, selling an estimated $17.8M.
  • Calamos Advisors's ten largest holdings make up 20% of its $26.7B portfolio in Q4 2021.
  • Calamos Advisors opened 232 new positions and closed 114 in Q4 2021.
  • Calamos Advisors's portfolio value rose 17% quarter-over-quarter to $26.7B.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.